Dr. Deepak Kanojia obtained his Ph.D. from the Cancer Research Institute, India (2010) where he identified alterations in keratin and associated proteins during carcinogenesis. He then went to the University of South Carolina for his first postdoctoral work on breast tumor initiating cells (TIC). He identified and characterized TIC from HER2/Neu transgenic mice using cell membrane markers and tumorsphere culture method. He then identified through systematic screening that TGF-beta signaling is critical for maintenance of TIC. Dr. Kanojia’s present interest spans the area of identification and targeting of malignant cancer cells. His work in Dr. Lesniak’s laboratory will focus on targeting brain tumor cells using modified stem cells.

View a partial list of Dr. Kanojia's publications through the National Library of Medicine's PubMed online database.

Email: [email protected]

---